HOME >> MEDICINE >> NEWS
Nuclear weapons continue to pose a serious health risk in Europe

Nuclear weapons in various European countries, particularly Russia, pose a serious threat to health, argues a letter in this week's BMJ.

Recent estimates are that Russia alone has 7,800 operational nuclear warheads - some of which are on high alert status says Nick Wilson, a public health lecturer and member of International Physicians for the Prevention of Nuclear War. Their continued presence means that accidental explosion or missile launch is always a threat. There is also a risk of nuclear weapon materials being stolen or sold on to terrorists, he argues.

Maintaining these weapons eats in to national economies adds the author, leaving less funds for healthcare and other vital services.

The threat posed by these weapons can only be tackled if European countries progress quickly towards a Europe free of nuclear weapons, and relevant countries - particularly Russia, France and the UK - meet their nuclear disarmament obligations. Within Europe, states with US nuclear weapons based on their territories should follow Greece in removing these weapons, says the author.

These weapons are "not able to deal with real security threats now facing the world", concludes the author. Unless removed they will continue to put European countries and others at risk.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
21-Jul-2005


Page: 1

Related medicine news :

1. New update of international health system comparisons: US continues to lag on most measures
2. Study shows continued success for new HPV vaccine against virus responsible for cervical cancer
3. Women on osteoporosis drug can discontinue use with no risk
4. Hospital palliative care programs continue rapid growth
5. Bone mass continues to increase in liver transplant patients, despite early loss
6. Researchers continue studies into aging and cognition
7. Media availability: New results show some severe emphysema patients continue to benefit from surgery
8. Health risks continue well after the surgery is over
9. Terminally ill patients continue to receive aggressive treatment at end of life
10. Cancer worries continue long after treatment ends
11. Prevalence of overweight children, teens and men in US continues to rise

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... ... January 17, 2017 , ... Mirror Mirror Beauty Boutique, ... highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, ... this elite group of providers. , Produced by Zeltiq, CoolSculpting is approved by ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... will lecture to primary eye care practitioners on the latest breakthroughs in the ... 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, ...
(Date:1/17/2017)... ... January 17, 2017 , ... Neil H. Greco Insurance Agency, a northern New ... the region, is launching a charity drive to raise awareness of heart disease and ... killer in America, and is responsible for 1 in every 4 deaths at the ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley ... double blind clinical study for its dental gel that shows significant reduction in plaque ... toothpaste containing triclosan. The study was conducted at the Beckman Laser Institute at UC ...
(Date:1/17/2017)... Tyler, TX (PRWEB) , ... January 17, 2017 ... ... serving Texas families from two offices in Tyler, has announced the latest beneficiary ... Red Ribbon Wish Network, a nonprofit organization dedicated to fulfilling the dreams of ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Inc ., a clinical-stage, cancer-selective gene therapy company, today announced ... development at Tocagen, will present at Phacilitate Cell & Gene ... Miami . Details of the podium ... ... what to do when and why Date and Time: Wednesday, Jan. ...
(Date:1/17/2017)... Research and Markets has announced the addition ... Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug (OTC, ... report to their offering. ... The global active pharmaceutical ingredients market is expected ... in 2016, growing at a CAGR of 6.3% from 2016 to ...
(Date:1/17/2017)... -- Immune Pharmaceuticals (NASDAQ: IMNP ) ("Immune"), ... will hold a Satellite Symposium on February 20th, 2017 at ... Munich, Germany . The ... for the maintenance of remission in AML with Ceplene" ... 2017 from 12:45 – 13:45 CET in Lecture Hall ...
Breaking Medicine Technology:
Cached News: